81 (Janumet XR metformin extended-release 1000 mg and sitagliptin 100 mg)
Generic Name: metformin/sitagliptin
Pill imprint 81 has been identified as Janumet XR metformin extended-release 1000 mg and sitagliptin 100 mg.
Janumet XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Janumet XR metformin extended-release 1000 mg and sitagliptin 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- metformin extended-release 1000 mg and sitagliptin 100 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Merck & Co., Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- povidone k29/32
hypromellose 2208 (100000 mPa.s)
sodium stearyl fumarate
polyethylene glycol 3350
hypromellose 2910 (6 mPa.s)
hydroxypropyl cellulose (type h)
FD&C Blue No. 2
More about Janumet XR (metformin / sitagliptin)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.